AI Blood Test Predicts Heart Disease Risk Up to 15 Years in Advance
Researchers at the University of Hong Kong have developed an innovative AI-powered blood test, CardiOmicScore, capable of predicting serious heart and circulation problems up to 15 years before they occur. This advanced test analyzes a vast array of thousands of proteins and metabolites within a blood sample. Its purpose is to estimate an individual's risk for six major cardiovascular diseases. These include critical conditions such as heart attack, stroke, heart failure, and atrial fibrillation. Significantly, CardiOmicScore differs from traditional genetic risk scores, which provide a static risk assessment throughout a person's life. Instead, this new system dynamically captures biological changes. These changes reflect a person's current health status, their lifestyle choices, and environmental factors impacting their well-being. The development offers a promising new tool for early intervention and personalized cardiovascular care.
The development of CardiOmicScore represents a significant advancement in predictive healthcare, moving beyond static genetic predispositions to incorporate dynamic biological markers. This approach aligns with the increasing integration of AI in diagnostics, offering the potential for earlier and more personalized interventions. By analyzing a broad spectrum of proteins and metabolites, the system aims to provide a more nuanced risk assessment that reflects real-time health and environmental influences. The challenge ahead will be validating these predictions across diverse populations and integrating such advanced diagnostics seamlessly into existing healthcare frameworks to ensure equitable access and effective clinical application, thereby transforming preventative cardiovascular care over the next decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.